Investment Research and Portfolio Monitoring Tools for the A.I. Era

MarketBeat All Access is the premier A.I. powered stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock ideas, A.I. stock analysis, best-in-class research tools, real-time alerts, proprietary research reports, and much more.

Start Your Free Trial Today

Free For 30 Days. Then, $39.99/month.

Get the Ultimate Investment Research Toolkit with MarketBeat All Access

Whether you are a professional trader or an every-day investor, these tools will help you become a more confident and profitable investor:

Top-Rated Stocks

Discover stocks with our top-rated stock lists, showcasing top recommendations from Wall Street's best-performing and most accurate research analysts.

Trending Stocks

Our trending stock tools monitor social media chatter and news sentiment in real-time to help identify hot stocks before you hear about them on the news.

The Idea Engine™

Powered by the latest artificial intelligence models, algorithmic factors, technical indicators, new Idea Engine™ stock ideas are released at the start of each week.

Proprietary Reports

Stay ahead of the curve with exclusive research reports about emerging industries and market trends, crafted by our expert analysts and reserved solely for All Access subscribers.

Stocks to Short

Pinpoint stocks recently affected by negative news or technical indicators - a helpful starting point for investors to identify potential risks or opportunities.

Portfolio Monitoring

All Access offers comprehensive portfolio monitoring and highly customizable real-time alerts, ensuring you stay informed about your stocks' performance and breaking news via email or SMS.

More All Access Benefits

Momentum Alerts
Live News Feed
Exclusive Stock Articles
Short Trading Ideas
Earnings Calls and Transcripts
Dividend Stock Ideas

Performance Ratings for Wall Street Analysts
1 Million+ Historical Analyst Ratings and Price Targets
Sector Performance Maps
Stock and ETF Screeners
Stock Comparison Tools

Media Sentiment Analysis Tools
Extended CSV/Excel Data Export Tools
Premium Newsletters
Priority Newsletter Delivery
Premium Customer Support
No Ads on MarketBeat.com

Start Your 30-Day Free Trial

Top Stock Ideas Your Ultimate Investment Research Toolkit

No matter what your investment strategy, MarketBeat All Access will help you find companies with the ingredients to outperform the market. Your subscription includes a suite of screeners and tools that help you easily search and identify stocks that align with your investment strategy.

6 Stock Screeners
75+ Technical Filters
12+ Industry Reports
15+ Exclusive Stock Lists
Unlimited Stocks in Your Watchlist

Start Your 30-Day Free Trial

a couple facing laptop and staring at it

Your Success is Our Success Take The Guesswork out of Investing

We believe that successful investing shouldn't be complicated, which is why MarketBeat All Access simplifies stock selection for our members by regularly providing new ideas and insights.

As a subscriber, you'll immediately receive our top stock ideas enabling you to spend less time navigating the complexities of the market and more time doing what you love.

Start Your 30-Day Free Trial

MarketBeat All Access on desktop and phone devices

Stock Ideas from The Idea Engine™

ATZ Aritzia

up 14.45% 90 days after 7/14/2025

The MarketBeat Idea Engine™ identified Aritzia as having a strong on 7/14/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $75.14 at the time of the recommendation. After 90 days, the stock was trading at $86.00, representing a 14.45% ROI. The current price for ATZ is $86.00.

EMR Emerson Electric

down 10.05% 90 days after 7/14/2025

The MarketBeat Idea Engine™ identified Emerson Electric as having a strong on 7/14/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $140.07 at the time of the recommendation. After 90 days, the stock was trading at $125.99, representing a -10.05% ROI. The current price for EMR is $128.68.

IREN IREN

up 268.27% 90 days after 7/14/2025

The MarketBeat Idea Engine™ identified IREN as having a strong on 7/14/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $16.23 at the time of the recommendation. After 90 days, the stock was trading at $59.77, representing a 268.27% ROI. The current price for IREN is $64.87.

LEVI Levi Strauss & Co.

down 1.54% 90 days after 7/14/2025

The MarketBeat Idea Engine™ identified Levi Strauss & Co. as having a strong on 7/14/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $21.91 at the time of the recommendation. After 90 days, the stock was trading at $21.57, representing a -1.54% ROI. The current price for LEVI is $21.63.

NVDA NVIDIA

up 11.06% 90 days after 7/14/2025

The MarketBeat Idea Engine™ identified NVIDIA as having a strong on 7/14/2025. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $164.92 at the time of the recommendation. After 90 days, the stock was trading at $183.16, representing a 11.06% ROI. The current price for NVDA is $187.58.

Trusted By Many All Access Empowers Individual Investors

"I'm not kidding — I made my money back for the initial MarketBeat subscription in about 11 minutes."

– Barry S. from Lanesborough, Massachusetts

(Barry's results are not typical. Your experience with MarketBeat All Access may vary.)

"I’m on the MarketBeat website every day. I regularly read the reports and use all the screeners."

– John M. from Atlanta, Georgia

"MarketBeat gives me the data and confidence to stay in control of my investing."

– Matt K. from Lenexa, Kansas

Very worthwhileMarketBeat is a valuable plethora of up-to-date market information from earnings reports to politician's stock buys and sell. Daily stock reports keep you informed on the market and stocks you are interested in. It also provides up to minute information on your portfolio and a weekly stock pick to examine. Very worthwhile.

— Gary K.
10/2/2025

My #1 go to sourceMy #1 go to source for a quick summary of my portfolio, with trend lines, daily analysis and articles on many of my holdings.

— Bill G.
9/30/2025

Excellent daily perspective on the marketsIn my experience, MarketBeat has proved to be an excellent value. The information is timely concise and well presented. I enjoy reading the well informed guest editorials. MarketBeat gives me an excellent daily perspective on the markets.

— Gary W.
9/30/2025

So informative and well doneI love to get the analysts' on stocks from MarketBeat - which stocks' rating went up, or were downgraded or when new coverage was initiated. This has helped me not only monitor stocks in my current portfolio, but open my eyes to other stocks that I hadn't considered or was not even aware of. There are also many great articles that come to my inbox from MarketBeat on the status of stocks or comparison of stocks or hot stocks in a sector or whatever it may be. They are so informative and well done.

— Vivian L.
9/29/2025

MarketBeat All Access is used by enthusiastic beginners and professional traders from these firms and more:

11,660

All Access Subscribers

6,213,279

Community Members

90,204,145

Traders Per Year

Free Trial Offer You are only one step away from gaining access to world-class investing tools and research.

Get Your 30-Day Free Trial of MarketBeat All Access Today!

Annual Billing

$399.00/year

Save $80.88 with annual billing!

Monthly Billing

$39.99/month

Experience MarketBeat All Access Risk-Free with Our 30-Day Free Trial

We're confident you'll discover the immense value of MarketBeat All Access during your free 30-day trial that we offer it with no strings attached. If you decide to cancel within the first 30 days, you can do so online with no questions asked.

Try it out – you have nothing to lose.

Start Your 30-Day Free Trial